NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Barrick Gold

(ABX)

upgraded at Credit Suisse to Outperform from Neutral on increased gold price forecasts. Price target lifted to $54 from $47.

Aruba Networks

(ARUN)

downgraded at Barclays to Equal Weight from Overweight. Valuation call. Price target held at $15.

Bank of Hawaii

(BOH) - Get Report

reinstated at BofA/Merrill with a Neutral rating. The company has demonstrated strong profitability while note participating in TARP or cutting its dividend, but that's already priced into shares. $49 price target.

Carnival

(CCL) - Get Report

downgraded at Argus from Buy to Hold. Recent slowdown in cruise demand could weigh on the stock.

Canadian Pacific

(CP) - Get Report

downgraded at BofA/Merrill to Neutral from Buy as flooding damages need time and money to be repaired. Price target dropped to $62 from $68.

Cisco Systems

(CSCO) - Get Report

rated new Buy at Kaufman Bros. $30 price target. Company is positioned well to benefit from industry trends.

CVB Financial

(CVBF) - Get Report

upgraded at Sterne Agee from Sell to Neutral. Company is positioned well to benefit from a rally in 10-year bonds.

Genzyme

(GENZ)

downgraded at Leerink to Market Perform. Stock has outperformed the past few months and appears to have limited upside potential.

Home Depot

(HD) - Get Report

downgraded at Janney from Buy to Neutral. Recovery in the housing market remains elusive. $30 price target.

Health Management

(HMA)

upgraded at Leerink from Market Perform to Outperform. Stock has pulled back and the company has the best volume growth in the industry.

Carmax

(KMX) - Get Report

estimates, target boosted at UBS. Shares of KMX now seen reaching $23. Estimates also upped, given higher realize margins. Sell rating.

Carmax

(KMX) - Get Report

upgraded at UBS from Neutral to Buy. $28 price target. Estimates also boosted, given better pricing and higher expected income from auto financing.

Grand Canyon Education

(LOPE) - Get Report

rated new Outperform at Baird. $33 price target. Company can deliver 25%-plus annual growth over the next three years.

Lowe's

(LOW) - Get Report

downgraded at Janney from Buy to Neutral. $22 price target. Housing sales should drop off, following the end of government stimulus.

Progress Energy

(PGN)

upgraded at FBR from Underperform to Market Perform. $41 price target. Company offers investors safety.

Pinnacle West Capital

(PNW) - Get Report

upgraded at Barclays to Overweight from Equal Weight as the company is leveraged to a pick up in the Phoenix economy. Price target raised to $40.

PPL

(PPL) - Get Report

upgraded at Deutsche from Hold to Buy. $30 price target. Potential overhangs have been lifted from the stock.

TRW Automotive

(TRW)

downgraded at Keybanc from Buy to Hold. Company derives more than half of its sales from Europe.

Wilmington Trust

(WL)

upgraded at Davenport from Neutral to Buy. $15 price target. Stock is down 40% over the past two months, creating an attractive entry point.

Wynn Resorts

(WYNN) - Get Report

upgraded at Sterne Agee from Buy to Neutral. $115 price target. Company should continue to post solid growth in Macau.

STOCK COMMENTS / EPS CHANGES

Bed Bath & Beyond

(BBY) - Get Report

price target cut at Barclays by a dollar to $46. Strong 1Q10 results but weak guidance. Equal Weight rating.

CH Robinson

(CHRW) - Get Report

estimates cut at Morgan Stanley through 2011. Higher spot rates could hurt earnings, but this is likely already priced into the stock. Equal-weight rating.

Danaher

(DHR) - Get Report

price target changed at Barclays. DHR price target adjusted to $50 from $100 to account for stock split. Overweight rating.

L-3 Communications

(LLL) - Get Report

numbers cut at Goldman through 2012. SSPD has been suspended from receiving any new contracts. Sell rating and new $69 price target.

Nike

(NKE) - Get Report

estimates lowered at UBS through 2012. Margin pressures are mounting. Neutral rating and $77 price target.

Paychex

(PAYX) - Get Report

price target lower at Barclays by a dollar to $28 on positive 4Q10 results but weak 1Q11estimates. Equal Weight rating.

Pfizer

(PFE) - Get Report

price target cut at Credit Suisse to $21 from $22 as launch of pain relief drug, Tanezumab, was pushed back. Maintain Outperform rating.

Pioneer Natural

(PXD) - Get Report

numbers increased at UBS. Shares of PXD now seen reaching $70, according to UBS. Estimates also raised, given the recent asset sale. Neutral rating.

Sandisk

(SNDK)

estimates, target boosted at Sterne Agee. Shares of SNDK now seen reaching $55. Estimates also upped, given the strength of new product cycles. Buy rating.

Skyworks

(SWKS) - Get Report

target raised at Morgan Stanley to $21. Company appears to be supplying more components to Apple. Overweight rating.

This article was written by a staff member of TheStreet.com.